The December wrap you WANT to read

STAT's top stories from December | 25% off an annual STAT+ subscription to dive into these stories.

My Account    STAT+ Check out December's top stories. If you like what you see, join the STAT+ community today – and enjoy 25% off your first year with code LOYAL25. Evan Vucci/AP 1   FDA to lower number of trials required for approval of drugs, other medical products By Lizzy Lawrence Mike Reddy for STAT 2   Data on Humana's clinics looked dismal. Then its corporate research machine got to work By Casey Ross and Tara Bannow Adobe 3   Aging startup backed by Sam Altman chases $5 billion valuation By Allison DeAngelis 25% off STAT+ Get 25% off your first year of STAT+ with discount code LOYAL25. SUBSCRIBE NOW More Top Stories 4   Trump has 'shaken the hell' out of the 80-year research pact between the government and universities. What now? By Megan Molteni, Anil Oza, and J. Emory Parker 5   FDA voucher program has become vehicle for political interference in drug review decisions, staffers say By Lizzy Lawrence 6   Top drug regulator Richard Pazdur set to leave the FDA By Lizzy Lawrence 7   In a banner year for biopharma, here are the best industry CEOs of 2025 By Adam Feuerstein 8   Wave's 'gym bro' obesity drug is story over substance By Adam Feuerstein 9   I'm the former head of Pfizer R&D. I'm very worried about biopharma's future By John L. LaMattina 10   The Worst Biopharma CEO of 2025 made decisions with tragic consequences By Adam Feuerstein read more STAT, 1 Exchange Place, Boston, MA ©2026, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us